Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CHR NYSE:FC NASDAQ:NEO NYSE:NYX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHRCheer$1.84-5.2%$1.54$1.00▼$3.45$21.41M1.0373,829 shs16,602 shsFCFranklin Covey$18.64-5.4%$21.80$18.58▼$44.16$249.17M0.91127,301 shs145,816 shsNEONeoGenomics$5.16+6.6%$6.99$4.72▼$19.11$666.56M1.552.52 million shs4.53 million shsNYX(NYX)$0.00$0.00▼$0.00N/AN/AN/AN/AElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHRCheer-5.15%-2.65%+7.61%+26.95%-37.84%FCFranklin Covey-5.48%-8.68%-22.85%-12.03%-57.36%NEONeoGenomics+6.61%-17.97%-30.27%-32.99%-70.90%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCHRCheer1.3905 of 5 stars0.05.00.00.02.01.70.6FCFranklin Covey3.8307 of 5 stars3.52.00.00.02.62.53.1NEONeoGenomics4.1213 of 5 stars4.25.00.00.02.13.31.3NYX(NYX)N/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCHRCheer 0.00N/AN/AN/AFCFranklin Covey 3.00Buy$31.0066.31% UpsideNEONeoGenomics 2.33Hold$12.88149.52% UpsideNYX(NYX) 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest NYX, CHR, NEO, and FC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/30/2025NEONeoGenomicsMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetEqual Weight ➝ Equal Weight$10.00 ➝ $8.007/30/2025NEONeoGenomicsBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Neutral7/29/2025NEONeoGenomicsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$8.50 ➝ $8.007/29/2025NEONeoGenomicsWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Market Perform7/7/2025FCFranklin CoveyRoth CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$30.00 ➝ $27.007/3/2025FCFranklin CoveyBarrington ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$35.005/15/2025NEONeoGenomicsGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral5/6/2025NEONeoGenomicsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetOverweight ➝ Overweight$18.00 ➝ $12.00(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCHRCheer$147.20M0.15$2.75 per share0.67$27.69 per share0.07FCFranklin Covey$287.23M0.82$2.56 per share7.27$5.19 per share3.59NEONeoGenomics$689.19M0.97$0.47 per share11.03$6.61 per share0.78NYX(NYX)$1.32M0.00N/AN/AN/ANaNCompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCHRCheer$25.97MN/A0.00∞N/AN/AN/AN/AN/AFCFranklin Covey$23.40M$0.7923.6013.811.593.81%19.08%6.12%N/ANEONeoGenomics-$78.73M-$0.81N/A57.33N/A-15.10%-2.72%-1.54%N/ANYX(NYX)-$11.11MN/A0.00N/AN/A-1,448.26%N/A-309.89%N/ALatest NYX, CHR, NEO, and FC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/2/2025Q3 2025FCFranklin Covey-$0.08$0.18+$0.26-$0.11$67.49 million$67.12 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCHRCheerN/AN/AN/AN/AN/AFCFranklin CoveyN/AN/AN/AN/AN/ANEONeoGenomicsN/AN/AN/AN/AN/ANYX(NYX)N/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCHRCheerN/A8.297.66FCFranklin Covey0.020.840.81NEONeoGenomics0.403.921.95NYX(NYX)N/A0.040.04Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCHRCheer18.54%FCFranklin Covey69.88%NEONeoGenomics98.50%NYX(NYX)N/AInsider OwnershipCompanyInsider OwnershipCHRCheer41.70%FCFranklin Covey15.50%NEONeoGenomics2.40%NYX(NYX)N/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCHRCheer12711.64 million6.78 millionN/AFCFranklin Covey1,08412.64 million10.68 millionOptionableNEONeoGenomics2,200129.18 million126.08 millionOptionableNYX(NYX)N/A15.56 millionN/ANot OptionableNYX, CHR, NEO, and FC HeadlinesRecent News About These CompaniesNYX PROFESSIONAL MAKEUP REIMAGINES BACK-TO-SCHOOL WITH AN INTERACTIVE BEAUTY EXPERIENCE ON ROBLOXJuly 31 at 6:46 PM | tmcnet.comNightfall launches ‘Nyx,’ an AI that automates data loss prevention at enterprise scaleJuly 30 at 11:56 PM | venturebeat.comVWWE NXT Results 7/29 - North American Championship On The Line, Lash Legend Faces Fallon HenleyJuly 30 at 6:55 PM | msn.comNia Jax Makes Surprise Return To WWE NXTJuly 30 at 6:55 PM | msn.comWWE NXT live results: Santino Marella challenges for North American titleJuly 30 at 6:55 PM | f4wonline.comFNXT results, live blog: Santino Marella challenges for a titleJuly 30 at 6:55 PM | msn.comWWE NXT Results, Winners, Live Grades, Reaction and Highlights From July 29July 30 at 12:05 PM | bleacherreport.comBNia Jax Appears On WWE NXTJuly 30 at 12:05 PM | msn.comNightfall Unveils First AI-Native DLP Copilot to Pave the Way for Autonomous SecurityJuly 30 at 12:05 PM | finance.yahoo.comNYX Professional Makeup partners with Angel City FC stars Alyssa, Gisele ThompsonJuly 29, 2025 | drugstorenews.comDWWE NXT (July 29) Live Streaming: It's Page vs Marella in North American title match - Preview, Start Time, and other detailsJuly 29, 2025 | msn.comLate to the Trend, But I Had to Try It | Epic Ink Liner by NYXJuly 29, 2025 | msn.comUlta Just Released a Breathtaking New Shade of This Fan Favorite HighlighterJuly 26, 2025 | msn.comWWE HOFer Advises Jacy Jayne In Surprise NXT AppearanceJuly 23, 2025 | msn.comYou’re Standing Next to Nyx – The Primordial Goddess of the Night ExplainedJuly 21, 2025 | msn.comNYX PROFESSIONAL MAKEUP TEAMS UP WITH U.S. SOCCER STARS AND SISTERS ALYSSA AND GISELE THOMPSONJuly 21, 2025 | finance.yahoo.comEXCLUSIVE: Nyx Professional Makeup Taps Soccer Sisters Alyssa and Gisele Thompson for ‘Make Them Look’ CampaignJuly 21, 2025 | msn.comA decade after launch, I finally figured out how to make The Sims 4 funJuly 18, 2025 | msn.comNYX Enters Israel. But Is It More Than Just a Social-Driven Hype Machine?July 16, 2025 | msn.comJacy Jayne Beats Jordynne Grace to Win NXT Title at Historic WWE Evolution PLEJuly 13, 2025 | bleacherreport.comBNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military Spend3 Short Squeeze Candidates With Big Catalysts on the HorizonBy Dan Schmidt | July 25, 2025View 3 Short Squeeze Candidates With Big Catalysts on the HorizonHow a Government Loan Changes the Game for Plug PowerBy Jeffrey Neal Johnson | July 4, 2025View How a Government Loan Changes the Game for Plug PowerAmerica Wants Drone Dominance: Are These Stocks Ready to Soar?By Chris Markoch | July 20, 2025View America Wants Drone Dominance: Are These Stocks Ready to Soar?Could Dutch Bros Dethrone Starbucks? Why Investors Are Perking UpBy Jordan Chussler | July 7, 2025View Could Dutch Bros Dethrone Starbucks? Why Investors Are Perking UpNYX, CHR, NEO, and FC Company DescriptionsCheer NASDAQ:CHR$1.84 -0.10 (-5.15%) Closing price 08/1/2025 03:54 PM EasternExtended Trading$1.84 -0.01 (-0.27%) As of 08/1/2025 04:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cheer Holding, Inc., through its subsidiaries, provides advertisement and content production services in the People's Republic of China. It operates through Cheers APP Internet Business and Traditional Media Businesses segments. The company also engages in mobile and online advertising, and media and entertainment businesses. In addition, it operates CHEERS app, an integrated e-commerce service with professionally produced content; CHEERS Video app, a media platform that engages users with content; and CHEERS e-Mall, an e-Mall app that offers products to the users through third party merchants through live streaming, online short videos, and online games. The company also provides CHEERS Telepathy, an artificial intelligence content creation platform; CHEERS Open Data, a platform that provides industry solutions; CheerCar, an interactive entertainment app; CheerReal, a digital collection NFT app; and production, such as short videos, online variety shows, online drama, live stream, and Cheers series. In addition, it is developing CheerChat App, a social app; and CHEERS Metaverse, a platform to provide immersive digital experiences. The company was formerly known as Glory Star New Media Group Holdings Limited and changed its name to Cheer Holding, Inc. in November 2023. Cheer Holding, Inc. was founded in 2016 and is headquartered in Beijing, the People's Republic of China.Franklin Covey NYSE:FC$18.64 -1.07 (-5.43%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$18.62 -0.02 (-0.11%) As of 08/1/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Franklin Covey Co. provides training and consulting services in the areas of execution, sales performance, productivity, customer loyalty, and educational improvement for organizations and individuals worldwide. The company operates through Direct Offices, International Licensees, and Education Practice segments. It also provides a suite of individual-effectiveness and leadership-development training and products. In addition, the company operates Strive platform, a learning deployment platform; Impact platform that helps automate implementation of learning initiatives; All Access Pass, a subscription platform that enables improved deployment of content, services, technology, and metrics to deliver behavioral impact at scale; and Leader in Me, which provides access to digital versions of student leadership guides, leadership lessons, illustrated leadership stories, and other resources. Franklin Covey Co. was incorporated in 1983 and is headquartered in Salt Lake City, Utah.NeoGenomics NASDAQ:NEO$5.16 +0.32 (+6.61%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$5.16 0.00 (-0.10%) As of 08/1/2025 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.(NYX) NYSE:NYXNYSE Euronext is a global operator of financial markets and provider of trading solutions. The Company offers a range of products and services in cash equities, futures, options, swaps, exchange-traded products, bonds, clearing operations, market data, and commercial technology solutions, all designed to meet the needs of investors, issuers, financial institutions and market participants. NYSE Euronext operates under three segments: Derivatives, Cash Trading and Listings, and Information Services and Technology Solutions. The Company's primary sources of revenue include its transaction and clearing fees, consisting of fees from its cash trading, derivatives trading and clearing businesses, revenues from the dissemination of its market data in the United States and Europe, listing fees and annual fees applicable to companies listed on its securities exchanges. Effective September 9, 2013, NYSE Euronext acquired an undisclosed minority stake, in ACE Group Inc. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/28 - 08/01 Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale AbbVie Stock Eyes Breakout as Pipeline and Profits Grow Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
